AI/ML Innovations Inc. Introduces "The Neural Net Store"
AI/ML Innovations Inc. Introduces "The Neural Net Store"
Highlights:
亮點：
- Convenience: The Neural Net Store is a commercial portal offering access to AIML's suite of healthcare applications.
- Flexibility: AIML's healthcare tools are accessible as both APIs and cloud-based services.
- Unlock Value with Micropayments: Monetize each Neural Net use with a simple click.
- 便捷性：神經網絡商店是一個商業門戶，提供訪問AIML的一套醫療保健應用。
- 靈活性：AIML的醫療保健工具可作爲API和基於雲的服務訪問。
- 微支付解鎖價值：每次神經網絡使用均可輕鬆轉化爲收益。
VICTORIA, BC / ACCESSWIRE / May 28, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is proud to introduce its online commercial portal, The Neural Net Store (The NNStore).
2024年5月28日，加拿大卑詩省維多利亞市/ ACCESSWIRE / AI/ML創新公司（“AIML”或“公司”）（CSE:AIML）（OTCQB:AIMLF）（FWB:42FB），是一家致力於收購併推進人工智能/機器學習技術以解決緊迫社會需求的領先公司，自豪地推出其在線商業門戶Neural Net Store（NNStore）
The NNStore offers flexible, affordable, commercial access to AIML's proprietary, AI-driven healthcare solutions that include the Follow Your Heart product suite for Blood Pressure measurement, as well as the Company's recently acquired Long ECG Neural Network analytical tool.
NNStore提供靈活、合理的商業訪問AIML的專有及基於人工智能驅動的醫療保健解決方案，包括血壓測量的Follow Your Heart產品套件，以及公司最近收購的Long ECG神經網絡分析工具。
Commercial transactions in The NNStore are completed in two ways:
NNStore商業交易有兩種完成方式：
- A Downloadable API Product:
- 可下載的API產品：開發者可以通過從NNStore許可證（或購買）並下載我們的專有API，將AIML的醫療解決方案直接集成到他們的第三方應用程序中。
Developers can integrate AIML's healthcare solutions directly into their third-party applications via the licensing (or purchase) and downloading of our proprietary APIs from the NNStore.
API的知名示例包括Google Fit、Google Maps、PayPal和YouTube。
Well-known examples of APIs include Google Fit, Google Maps, PayPal, and YouTube.
Web應用神經網絡服務（NNaaS）：用戶還可以通過我們的神經網絡雲解決方案輕鬆、成本效益地訪問AIML的醫療工具。這樣，就不需要建立自己的web基礎架構。我們的在線可定製管理控制檯允許許可用戶在不需要任何技術知識或處理能力的情況下運行我們的神經網絡web應用程序，因爲專有技術和處理能力存儲在我們的服務器上，而不是在用戶的計算機上或醫療設備上。例如，用戶只需上傳ECG文件到我們的Long ECG NN，即可快速準確地檢索所有標籤化的心跳數據表格。
- A Web Application Neural Net Service (NNaaS):
- 這種模式的成功例子包括生產力門戶，如Goole Docs和Microsoft Office、商業門戶，如eBay和Amazon，以及以人工智能爲中心的Web門戶，如ChatGPT。
Users also enjoy the option of the ease and cost effectiveness of accessing AIML's healthcare tools online, via our neural network cloud solution - thereby eliminating the need of setting up their own web infrastructure. Our online customizable Admin Console allows licensed users to run our neural network web applications without the need for any technical knowledge or processing power, as the proprietary technology and processing power resides on our servers, not the user's computer or medical devices. For example, users simply upload an ECG file to our Long ECG NN, and retrieve a spreadsheet with all the heartbeats labeled - accurately and quickly.
這些基於Web的交易可以按使用頻率的覆蓋次數單獨許可，並針對頻繁/商業用戶提供訂閱。
Successful examples of this model include productivity portals such as Goole Docs and Microsoft Office, commercial portals such as eBay and Amazon, and AI-centric web portals such as ChatGPT.
AI/ML創新公司的CPO Esmat Naikyar表示：“推出NNStore，我們自豪地推出了神經網絡作爲服務（NNaaS），這是神經網絡資產開發和交付的獨特模型，通過雲基礎架構。NNStore使醫療組織中的技術和開發團隊能夠創建無縫集成AIML專有AI驅動的健康解決方案的雲基礎架構。此服務有利於包括設備公司、醫院、製藥企業在內的廣泛組織。此外，醫療保健團隊、專家和研究人員可以直接通過Web門戶訪問我們的解決方案，無需開發自己的集成應用程序。NNStore從根本上消除了醫療組織採用人工智能和神經網絡解決方案的障礙。通過實現簡單易用，它還可以讓組織利用其匿名歷史數據發現新的見解，發現數字生物標誌物，並推動更快、更高效的醫療保健創新。”
These web-based transactions can be licensed either on a per-use basis by the infrequent/retail user, or by way of a subscription for frequent/commercial users.
這些基於Web的交易可以按使用頻率的覆蓋次數單獨許可，並針對頻繁/商業用戶提供訂閱。
Esmat Naikyar, CPO of AI/ML Innovations Inc, stated "With the launch of NNStore, we proudly introduce our Neural Network as a Service (NNaaS), a unique model for the development and delivery of neural network assets through cloud infrastructure.
首席產品官Esmat Naikyar表示：“推出NNStore，我們自豪地推出了神經網絡作爲服務（NNaaS），這是神經網絡資產開發和交付的獨特模型，通過雲基礎架構。
NNStore empowers tech and developer teams in healthcare organizations to create cloud infrastructures that seamlessly integrate AI/ML's proprietary AI-driven health solutions. This service benefits a wide range of organizations, including device companies, hospitals, pharmaceuticals and many more. Additionally, healthcare teams, specialists, and researchers can directly access our solutions through the web portal, avoiding the need to develop their own integration applications.
NNStore賦予了醫療組織中的技術和開發團隊創建無縫集成AIML專有AI驅動的健康解決方案的雲基礎架構：包括設備公司、醫院、製藥企業等等。另外，醫療保健團隊、專家和研究人員可以直接通過Web門戶訪問我們的解決方案，無需開發自己的集成應用程序。NNStore從根本上消除了醫療組織採用人工智能和神經網絡解決方案的障礙。通過實現簡單易用，它還可以讓組織利用其匿名歷史數據發現新的見解，發現數字生物標誌物，並推動更快、更高效的醫療保健創新。”
The NNStore fundamentally eliminates barrier to adoption of AI and neural network solutions for healthcare organizations. By enabling easy implementation, it also allows organizations to leverage their anonymized historical data to uncover new insights, discover digital biomarkers, and drive faster and more efficient healthcare innovations."
AI/ML Innovations Inc.已重新調整其業務運營以利用人工智能（AI）和機器學習（ML）的蓬勃發展，初始投資重點放在利用AI、ML、雲計算和數字平台推動變革性健康管理解決方案和精準支持交付的新興數字健康和健康公司上。通過與健康儀表盤（AIML持有95.2%的所有權）、Tech2Heal（最高持股22%，目前AIML擁有12.44%的所有權）、AI Rx Inc.（AIML持有70%的所有權）和其他計劃中的增值投資進行戰略合作，該公司繼續利用不斷擴大的增長領域，造福於公司的所有利益相關者。AI/ML的股票在加拿大證券交易所上市，代碼爲“AIML”，在OTCQB Venture Market上市，代碼爲“AIMLF”，在Frankfurt Stock Exchange上市，代碼爲“42FB”。
###
###
About AI/ML Innovations Inc.
執行董事Tim Daniels
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
更多關於AI/ML創新公司的信息
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
謹代表董事會
AI/ML Innovations Inc.已重新調整其業務運營以利用人工智能（AI）和機器學習（ML）的蓬勃發展，初始投資重點放在利用AI、ML、雲計算和數字平台推動變革性健康管理解決方案和精準支持交付的新興數字健康和健康公司上。通過與健康儀表盤（AIML持有95.2%的所有權）、Tech2Heal（最高持股22%，目前AIML擁有12.44%的所有權）、AI Rx Inc.（AIML持有70%的所有權）和其他計劃中的增值投資進行戰略合作，該公司繼續利用不斷擴大的增長領域，造福於公司的所有利益相關者。AI/ML的股票在加拿大證券交易所上市，代碼爲“AIML”，在OTCQB Venture Market上市，代碼爲“AIMLF”，在Frankfurt Stock Exchange上市，代碼爲“42FB”。
For more information about AI/ML Innovations:
執行董事Tim Daniels:
For detailed information please see AI/ML's website or the Company's filed documents at
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com
有關詳細信息，請參閱AI/ML網站或公司歸檔文件。
更多信息請聯繫：Blake Fallis (778) 405-0882或info@aiml-innovations.com。
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
CSE及其規則服務提供者（該術語在CSE的政策中定義）不對此公告的充分性或準確性承擔責任。
For AI/ML Innovations Investors
針對AI/ML Innovations投資者
Certain statements made in this press release that are not based on historical information are forward-looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations' expectations concerning management's plans, objectives, and strategies, including strategies for defending the Company's intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events, or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at .
此新聞稿中的某些陳述不是基於歷史信息，而是涉及到許多已知和未知風險和不確定性的前瞻性陳述。本新聞稿包含明示或暗示的關於AI/ML Innovations期望的前瞻性陳述，涉及到管理層的計劃、目標和策略，包括保護公司知識產權的策略。這些陳述既不是承諾也不是保證，但是受到各種風險和不確定性的影響，其中許多超出了我們的控制範圍，這可能導致實際結果與這些前瞻性陳述所預期的結果彼此不同。現有和潛在投資者被告知不要過度依賴這些前瞻性陳述，這些前瞻性陳述僅代表其所在日期的意見。AI/ML Innovations Inc.無需更新或修訂此新聞稿中所包含的信息，除非適用的證券法明確要求或有新信息或未來事件或情況。有關不確定性和風險的更多信息可以在AI / ML向證券監管機構提交的披露文件中找到，網址爲 。
SOURCE: AI/ML Innovations Inc.
來源：AI/ML Innovations Inc.
譯文內容由第三人軟體翻譯。